Sonendo

SONX · OTC

$1.28−$0.8561 (−40.08%)TodayMarket closed ·
No price history for this range.

About SONX

Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 131 full-time employees. The company went IPO on 2021-10-29. The firm develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to dissolve tissue and bacteria using minimal or no instrumentation. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The firm also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.

Employees
131
Headquarters
Laguna Hills, California
Listed
Oct 29, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies

SONX key statistics

Market cap
547.07K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
929
Volume
37
Open price
$1.28
High today
$1.28
Low today
$1.28
52 Week high
$1.90
52 Week low
$0.02

Sonendo (SONX) at a glance

As of Oct 14, 2026, Sonendo (SONX) shares are priced at $1.28, giving the company a market cap of 547.07K and a price-to-earnings ratio of 0.00.

Volume so far is 37 shares, below the average of 929 shares a day.

Over the past year Sonendo has ranged from $0.02 to $1.90, and now sits 67% of the way up that range.

Sonendo met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q4 FY24 it reported -$13.44 per share against an estimate of -$13.30.

SONX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 19.8% on average.

  1. Q1 FY23: reported -$32.00 per share against an estimate of -$30.60
  2. Q2 FY23: reported -$38.00 per share against an estimate of -$30.09
  3. Q3 FY23: reported -$28.00 per share against an estimate of -$28.05
  4. Q4 FY23: reported -$24.00 per share against an estimate of -$30.60
  5. Q1 FY24: reported -$26.00 per share against an estimate of $18.36
  6. Q2 FY24: reported -$16.00 per share against an estimate of -$24.48
  7. Q3 FY24: reported -$15.77 per share against an estimate of -$20.40
  8. Q4 FY24: reported -$13.44 per share against an estimate of -$13.30

SONX news

  • Press releaseBusiness Wire

    Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer

  • Press releaseBusiness Wire

    Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance

  • Press releaseBusiness Wire

    Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance

  • Press releaseBusiness Wire

    Sonendo, Inc. Announces $5.0 Million Private Placement

  • Press releaseBusiness Wire

    Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

  • Press releaseBusiness Wire

    Sonendo, Inc. Reports Third Quarter 2024 Financial Results

  • Press releaseBusiness Wire

    Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024

  • Press releaseBusiness Wire

    Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024

Similar companies

Companies in the same industry as Sonendo

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.